Medicine
Abecma 300000000 injectable suspension
Abecma 300000000 injectable suspension is a prescription medicine containing Idecabtagene vicleucel for intravenous use, marketed by Celgene, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store ABECMA frozen in the vapor phase of liquid nitrogen (less than or equal…
Key facts
- Active ingredient (INN)
- Idecabtagene vicleucel
- Brand
- Abecma
- Strength
- 300000000
- Dosage form
- Injectable suspension
- Route
- Intravenous
- Packs
- 1 suspension
- Marketing authorisation holder
- Celgene
- Manufacturer
- Celgene
- Origin register
- US FDA, United States
- Storage
- Store ABECMA frozen in the vapor phase of liquid nitrogen (less than or equal to minus 130°C).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01 Cancer medicines (antineoplastics)
- HS code (indicative)
- 3002.51Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 26 March 2021
- Identifiers
- RxCUI 2536434, 2536439, 2536443 +3DailyMed set ID b90c1fe7-f5cc-464e-958a-af36e9c26d7cNDC 59572-515Application BLA125736
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Idecabtagene vicleucel is a prescription medicine indicated for the treatment of adult patients with relapsed or refractory multiple myeloma after two or more prior lines of therapy including an immunomodulatory agent, among other approved uses. MedsAcross supplies Idecabtagene vicleucel for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Idecabtagene vicleucelFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Abecma prescribing information (Celgene) · U.S. National Library of Medicine, DailyMed
- Abecma: European public assessment report (EPAR) · European Medicines Agency
Need Abecma 300000000 injectable suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.